PROCR and breast carcinoma: However, in the current study, EVs thrombogenicity, as reflected in the levels of EVs: TF, TF/TFPI ratio, and EVs EPCR (count as soluble EPCR, a pro-thrombotic marker) were found to be similar in breast cancer and colorectal patients.